Loading...
Header Logo
Keywords
Last Name
Institution

ERIKA RESETKOVA

TitleAssociate Professor
InstitutionMD Anderson
DepartmentPathology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res. 2020 06 23; 22(1):69. PMID: 32576238.
      View in: PubMed
    2. Boros M, Resetkova E, Molnar C, Podoleanu C, Dema A, Olinca M, Alvarado-Cabrero I, Buiga R, Stolnicu S. Analysis of Clinical-Pathological Data with Impact on Overall Survival in Male Breast Carcinoma: An International Multi-Institutional Study of 217 Cases. Chirurgia (Bucur). 2020 May-Jun; 115(3):323-333. PMID: 32614287.
      View in: PubMed
    3. Dano H, Altinay S, Arnould L, Bletard N, Colpaert C, Dedeurwaerdere F, Dessauvagie B, Duwel V, Floris G, Fox S, Gerosa C, Jaffer S, Kurpershoek E, Lacroix-Triki M, Laka A, Lambein K, MacGrogan GM, Marchió C, Martinez DM, Nofech-Mozes S, Peeters D, Ravarino A, Reisenbichler E, Resetkova E, Sanati S, Schelfhout AM, Schelfhout V, Shaaban AM, Sinke R, Stanciu-Pop CM, Stobbe C, van Deurzen CHM, Van de Vijver K, Van Rompuy AS, Verschuere S, Vincent-Salomon A, Wen H, Bouzin C, Galant C, Van Bockstal MR. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study. Mod Pathol. 2020 03; 33(3):354-366. PMID: 31534203.
      View in: PubMed
    4. Wang S, Oh DY, Leventaki V, Drakos E, Zhang R, Sahin AA, Resetkova E, Edgerton ME, Wu W, Claret FX. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Cancer Lett. 2019 11 28; 465:12-23. PMID: 31473252.
      View in: PubMed
    5. Moseley TW, Shah SS, Nguyen CV, Rosenblat J, Resetkova E, Sneige N, Brandt KR, Huo L. Clinical Management of Mucocele-Like Lesions of the Breast with Limited or no Epithelial Atypia on Core Biopsy: Experience from Two Institutions. Ann Surg Oncol. 2019 Oct; 26(11):3478-3488. PMID: 31187364.
      View in: PubMed
    6. Stolnicu S, Moncea D, Dema A, Geambasu S, Moldovan C, Comanescu M, Voidazan S, Georgescu R, Alvarado-Cabrero I, Resetkova E, Buiga R. Androgen Receptor (AR) Expression in Invasive Male Breast Carcinoma (MBC): An International Multi-Institutional Review of 168 Cases Emphasizing the Potential Use of AR as a Therapeutic Target. Appl Immunohistochem Mol Morphol. 2017 02; 25(2):e18-e20. PMID: 28177976.
      View in: PubMed
    7. Schuh F, Biazús JV, Resetkova E, Benfica CZ, Ventura Ade F, Uchoa D, Graudenz M, Edelweiss MI. Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis. Diagn Pathol. 2015 Jul 10; 10:93. PMID: 26159429.
      View in: PubMed
    8. Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. 2015 Aug; 67(2):245-54. PMID: 25564996.
      View in: PubMed
    9. Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 2015 Apr; 22(4):1111-7. PMID: 25287438.
      View in: PubMed
    10. Burch-Smith R, Tannir NM, Resetkova E, Tamboli P, Rao P. Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. Chin J Cancer. 2014 Jul; 33(7):351-5. PMID: 24589208.
      View in: PubMed
    11. Resetkova E. A pictorial journey through variants of ductal carcinoma in situ (DCIS) and DCIS mimickers. Clin Breast Cancer. 2012 Oct; 12(5):347-63. PMID: 23040003.
      View in: PubMed
    12. Marian C, Boila A, Soanca D, Malau M, Podeanu DM, Resetkova E, Stolnicu S. Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: a report of two cases and review of literature. APMIS. 2013 Apr; 121(4):272-9. PMID: 23030630.
      View in: PubMed
    13. Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology. 2013 Jan; 62(2):267-74. PMID: 22963676.
      View in: PubMed
    14. Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CT. Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol. 2012 Sep; 36(9):1353-8. PMID: 22895267.
      View in: PubMed
    15. Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology. 2011 Jul; 59(1):106-15. PMID: 21668471.
      View in: PubMed
    16. Lee YS, Mathew J, Dogan BE, Resetkova E, Huo L, Yang WT. Imaging features of micropapillary DCIS: correlation with clinical and histopathological findings. Acad Radiol. 2011 Jul; 18(7):797-803. PMID: 21419669.
      View in: PubMed
    17. Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011 Aug; 42(8):1169-77. PMID: 21334720.
      View in: PubMed
    18. Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J. 2010 Nov-Dec; 16(6):573-80. PMID: 21070433.
      View in: PubMed
    19. Mehta R, Jain RK, Sneige N, Badve S, Resetkova E. Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast. J Clin Pathol. 2010 Aug; 63(8):744-7. PMID: 20702478.
      View in: PubMed
    20. Schuh F, Biazús JV, Resetkova E, Benfica CZ, Edelweiss MI. Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey. Pathol Res Pract. 2010 Oct 15; 206(10):705-11. PMID: 20663616.
      View in: PubMed
    21. Albarracin C, Edgerton ME, Gilcrease MZ, Huo L, Krishnamurthy S, Middleton LP, Resetkova E, Sahin AA, Sneige N, Fraser WS, Wu Y. Is it too soon to start reporting HER2 genetic heterogeneity? Arch Pathol Lab Med. 2010 Feb; 134(2):162-3; author reply 163. PMID: 20121597.
      View in: PubMed
    22. Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, Nakshatri H, Badve S. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat. 2010 Aug; 123(1):97-108. PMID: 19911270.
      View in: PubMed
    23. Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, Resetkova E, Le-Petross HT, Yang WT. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med. 2009 Feb; 50(2):231-8. PMID: 19164229.
      View in: PubMed
    24. Cao Y, Li Y, Edelweiss M, Arun B, Rosen D, Resetkova E, Wu Y, Liu J, Sahin A, Albarracin CT. Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol. 2008 Dec; 16(6):530-4. PMID: 18776816.
      View in: PubMed
    25. Dawood S, Resetkova E, Gonzalez-Angulo AM. Trastuzumab administration associated with change in HER2 status. Clin Breast Cancer. 2008 Aug; 8(4):366-9. PMID: 18757266.
      View in: PubMed
    26. Resetkova E, Edelweiss M, Albarracin CT, Yang WT. Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years' of experience at a single institution. Breast Cancer Res Treat. 2011 Jun; 127(2):335-43. PMID: 18626769.
      View in: PubMed
    27. Resetkova E. Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis. Semin Oncol. 2008 Feb; 35(1):25-32. PMID: 18308143.
      View in: PubMed
    28. Ferreira M, Albarracin CT, Resetkova E. Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol. 2008 Feb; 21(2):201-7. PMID: 18084246.
      View in: PubMed
    29. Gokhale S, Rosen D, Sneige N, Diaz LK, Resetkova E, Sahin A, Liu J, Albarracin CT. Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol. 2007 Dec; 15(4):451-5. PMID: 18091390.
      View in: PubMed
    30. Edelweiss M, Gupta N, Resetkova E. Preoperative diagnosis of clear cell "sugar" tumor of the lung by computed tomography-guided fine-needle biopsy and core-needle biopsy. Ann Diagn Pathol. 2007 Dec; 11(6):421-6. PMID: 18022127.
      View in: PubMed
    31. Yang WT, Le-Petross HT, Macapinlac H, Carkaci S, Gonzalez-Angulo AM, Dawood S, Resetkova E, Hortobagyi GN, Cristofanilli M. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2008 Jun; 109(3):417-26. PMID: 17653852.
      View in: PubMed
    32. May SA, Deavers MT, Resetkova E, Johnson D, Albarracin CT. Giant cell tumor of soft tissue arising in breast. Ann Diagn Pathol. 2007 Oct; 11(5):345-9. PMID: 17870021.
      View in: PubMed
    33. Bahrami A, Resetkova E, Ro JY, Ibañez JD, Ayala AG. Primary osteosarcoma of the breast: report of 2 cases. Arch Pathol Lab Med. 2007 May; 131(5):792-5. PMID: 17488168.
      View in: PubMed
    34. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer. 2007 Feb 15; 109(4):658-67. PMID: 17211865.
      View in: PubMed
    35. Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer. 2006 Oct 15; 107(8):1760-8. PMID: 16977650.
      View in: PubMed
    36. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res. 2006 Aug 01; 12(15):4598-604. PMID: 16899607.
      View in: PubMed
    37. Anderson P, Albarracin CT, Resetkova E. A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med. 2006 Apr; 130(4):e50-2. PMID: 16594759.
      View in: PubMed
    38. Resetkova E, Albarracin C, Sneige N. Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature. Am J Surg Pathol. 2006 Jan; 30(1):20-7. PMID: 16330938.
      View in: PubMed
    39. Resetkova E, Padula A, Albarraccin CT, Sneige N. Pathologic quiz case: a large, ill-defined cystic breast mass. Invasive cystic hypersecretory duct carcinoma. Arch Pathol Lab Med. 2005 Mar; 129(3):e79-80. PMID: 15737055.
      View in: PubMed
    40. Assad L, Resetkova E, Oliveira VL, Sun W, Stewart JM, Katz RL, Caraway NP. Cytologic features of renal medullary carcinoma. Cancer. 2005 Feb 25; 105(1):28-34. PMID: 15593260.
      View in: PubMed
    41. Padula A, Chin NW, Azeez S, Resetkova E, Andriko JA, Miettinen M. Primary gastrointestinal stromal tumor of the esophagus in an HIV-positive patient. Ann Diagn Pathol. 2005 Feb; 9(1):49-53. PMID: 15692952.
      View in: PubMed
    42. Resetkova E, Gonzalez-Angulo AM, Sneige N, Mcdonnell TJ, Buzdar AU, Kau SW, Yamamura Y, Reuben JM, Hortobagyi GN, Cristofanilli M. Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma. Cancer. 2004 Sep 01; 101(5):913-7. PMID: 15329897.
      View in: PubMed
    43. Resetkova E, Sahin A, Ayala AG, Sneige N. Breast carcinoma with choriocarcinomatous features. Ann Diagn Pathol. 2004 Apr; 8(2):74-9. PMID: 15060884.
      View in: PubMed
    44. Resetkova E, Flanders DJ, Rosen PP. Ten-year follow-up of mammary carcinoma arising in microglandular adenosis treated with breast conservation. Arch Pathol Lab Med. 2003 Jan; 127(1):77-80. PMID: 12521372.
      View in: PubMed
    45. Yao DX, Hoda SA, Yin DY, Kuhel WI, Harigopal M, Resetkova E, DeLellis RA. Interpretative problems and preparative technique influence reliability of intraoperative parathyroid touch imprints. Arch Pathol Lab Med. 2003 Jan; 127(1):64-7. PMID: 12521369.
      View in: PubMed
    46. Resetkova E, Hoda SA, Clarke JL, Rosen PP. Benign heterotopic epithelial inclusions in axillary lymph nodes. Histological and immunohistochemical patterns. Arch Pathol Lab Med. 2003 Jan; 127(1):e25-7. PMID: 12562290.
      View in: PubMed
    47. Hoda SA, Chiu A, Resetkova E, Harigopal M, Hoda RS, Osborne MP. Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions. Microsc Res Tech. 2002 Oct 15; 59(2):85-91. PMID: 12373718.
      View in: PubMed
    48. Resetkova E, Hoda SA. "Ossifying-type" mammary calcifications. Arch Pathol Lab Med. 2002 Aug; 126(8):995-6. PMID: 12197511.
      View in: PubMed
    49. Hoda SA, Resetkova E, Yusuf Y, Cahan A, Rosen PP. Megakaryocytes mimicking metastatic breast carcinoma. Arch Pathol Lab Med. 2002 May; 126(5):618-20. PMID: 11958674.
      View in: PubMed
    50. Resetkova E, Hoda SA. Images in pathology. Mammary crystalloids. Int J Surg Pathol. 2002 Apr; 10(2):148. PMID: 12075409.
      View in: PubMed
    51. Resetkova E, Padula A, Hoda SA. Pathologic quiz case. A pelvic mass with abdominal dissemination. Arch Pathol Lab Med. 2001 May; 125(5):703-4. PMID: 11300953.
      View in: PubMed
    52. Kawai K, Resetkova E, Enomoto T, Fornasier V, Volpé R. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice. J Clin Endocrinol Metab. 1998 Jan; 83(1):157-64. PMID: 9435434.
      View in: PubMed
    53. Togun RA, Resetkova E, Kawai K, Enomoto T, Volpé R. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus. Clin Immunol Immunopathol. 1997 Mar; 82(3):243-9. PMID: 9073547.
      View in: PubMed
    54. Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Proc Assoc Am Physicians. 1997 Mar; 109(2):126-35. PMID: 9069581.
      View in: PubMed
    55. Mukuta T, Arreaza G, Nishikawa M, Resetkova E, Jamieson C, Tamai H, Volpé R. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Clin Invest Med. 1997 Feb; 20(1):5-15. PMID: 9013039.
      View in: PubMed
    56. Mukuta T, Nishikawa M, Arreaza G, Resetkova E, Yoshikawa N, Fornasier V, Young E, Volpé R. The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue. Thyroid. 1996 Oct; 6(5):429-36. PMID: 8936667.
      View in: PubMed
    57. Resetkova E, Kawai K, Enomoto T, Arreaza G, Togun R, Foy TM, Noelle RJ, Volpé R. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. Thyroid. 1996 Aug; 6(4):267-73. PMID: 8875745.
      View in: PubMed
    58. Arreaza G, Yoshikawa N, Mukuta T, Resetkova E, Barsuk A, Nishikawa M, Muallim C, Miller N, Jamieson C, Volpé R. Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. J Clin Endocrinol Metab. 1995 Dec; 80(12):3724-31. PMID: 8530625.
      View in: PubMed
    59. Nishikawa M, Mukuta T, Arreaza G, Resetkova E, Poppema S, Tamai H, Volpé R, Lazarovits AI. Effects of monoclonal antibody against CD45RB on peripheral blood mononuclear cell proliferation and on HLA-DR and adhesion molecule expression on thyrocytes of patients with autoimmune thyroid disease. Thyroid. 1995 Aug; 5(4):265-72. PMID: 7488866.
      View in: PubMed
    60. Resetkova E, Nishikawa M, Mukuta T, Arreaza G, Fornasier VL, Volpé R. Homing of 51Cr-labeled human peripheral lymphocytes to Graves' thyroid tissue xenografted into SCID mice. Thyroid. 1995 Aug; 5(4):293-8. PMID: 7488871.
      View in: PubMed
    61. Mukuta T, Yoshikawa N, Arreaza G, Resetkova E, Leushner J, Song YH, Akasu F, Onaya T, Volpé R. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes. J Clin Endocrinol Metab. 1995 Apr; 80(4):1264-72. PMID: 7714099.
      View in: PubMed
    62. Yoshikawa N, Morita T, Arreaza G, Resetkova E, Mukuta T, Volpé R. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease. Clin Invest Med. 1995 Apr; 18(2):91-8. PMID: 7788961.
      View in: PubMed
    63. Yoshikawa N, Arreaza G, Morita T, Mukuta T, Resetkova E, Miller N, Volpé R. Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease. Horm Metab Res. 1994 Sep; 26(9):419-23. PMID: 7835825.
      View in: PubMed
    64. Morita T, Yoshikawa N, Akasu F, Asa SL, Miller N, Resetkova E, Arreaza G, Mukuta T, Jamieson C, Volpé R. Thyroid lymphomas in human thyroid tissue with autoimmune thyroid disease xenografted in severe combined immunodeficient mice. Endocr Pathol. 1994 Sep; 5(3):169-177. PMID: 32370444.
      View in: PubMed
    65. Yoshikawa N, Arreaza G, Mukuta T, Resetkova E, Miller N, Jamieson C, Nishikawa M, Inada M, Volpé R. Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice. Clin Endocrinol (Oxf). 1994 Jul; 41(1):31-9. PMID: 7519528.
      View in: PubMed
    66. Yoshikawa N, Arreaza G, Morita T, Mukuta T, Resetkova E, Akasu F, Miller N, Jamieson C, Volpé R. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice. J Clin Endocrinol Metab. 1994 Feb; 78(2):367-74. PMID: 8106624.
      View in: PubMed
    67. Resetkova E, Notenboom R, Arreaza G, Mukuta T, Yoshikawa N, Volpé R. Seroreactivity to bacterial antigens is not a unique phenomenon in patients with autoimmune thyroid diseases in Canada. Thyroid. 1994; 4(3):269-74. PMID: 7833662.
      View in: PubMed
    68. Yoshikawa N, Arreaza G, Mukuta T, Resetkova E, Miller N, Jamieson C, Volpé R. Studies of human thyroid xenografts from Hashimoto's thyroiditis in severe combined immunodeficient (SCID) mice: detection of thyroid stimulation-blocking antibody. Thyroid. 1994; 4(1):13-8. PMID: 7914445.
      View in: PubMed
    69. Volpé R, Akasu F, Morita T, Yoshikawa N, Resetkova E, Arreaza G, Mukuta T. New animal models for human autoimmune thyroid disease. Xenografts of human thyroid tissue in severe combined immunodeficient (SCID) and nude mice. Horm Metab Res. 1993 Dec; 25(12):623-7. PMID: 8119666.
      View in: PubMed
    70. Yoshikawa N, Morita T, Resetkova E, Arreanza G, Carayon P, Volpé R. Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease. J Endocrinol Invest. 1993 Sep; 16(8):609-17. PMID: 8258649.
      View in: PubMed
    71. Resetkova E, Morita T, Akasu F, Carayon P, Volpé R. In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease. Clin Invest Med. 1993 Aug; 16(4):256-64. PMID: 8306534.
      View in: PubMed
    72. Morita T, Yoshikawa N, Akasu F, Resetkova E, Arreaza G, Miller N, Jamieson C, Volpé R. Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice. J Clin Endocrinol Metab. 1993 Jul; 77(1):255-61. PMID: 8100830.
      View in: PubMed
    73. Volpé R, Kasuga Y, Akasu F, Morita T, Yoshikawa N, Resetkova E, Arreaza G. The use of the severe combined immunodeficient mouse and the athymic "nude" mouse as models for the study of human autoimmune thyroid disease. Clin Immunol Immunopathol. 1993 May; 67(2):93-9. PMID: 8519094.
      View in: PubMed
    74. Resetkova E, Arreaza G, Yoshikawa N, Morita T, Kim H, Carayon P, Volpé R. Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD). Clin Exp Immunol. 1993 Mar; 91(3):397-403. PMID: 8443962.
      View in: PubMed
    75. Akasu F, Morita T, Resetkova E, Miller N, Akasu R, Jamieson C, Volpé R. Reconstitution of severe combined immunodeficient mice with intrathyroidal lymphocytes of thyroid xenografts from patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1993 Jan; 76(1):223-30. PMID: 7678424.
      View in: PubMed
    76. Akasu F, Morita T, Resetkova E, Yoshikawa N, Carayon P, Volpé R. Sensitization of T lymphocytes to thyroglobulin and thyroperoxidase in autoimmune thyroid diseases. Autoimmunity. 1993; 14(4):261-8. PMID: 8102254.
      View in: PubMed
    77. Resetkova E, Morita T, Akasu F, Carayon P, Volpé R. Effect of human thyroglobulin on the production of platelet activating factor from peripheral blood mononuclear cells from patients with autoimmune thyroid diseases. Reg Immunol. 1992 Jul-Aug; 4(4):204-8. PMID: 1476872.
      View in: PubMed
    78. Strbák V, Giraud P, Resetková E, Ouafik LH, Dutour A, Oliver C, Povazanová K, Randuskovà A. Thyroliberin (TRH) and TRH free acid (TRH-OH) present in milk do not originate from local synthesis in mammary gland. Endocr Regul. 1991 Jun; 25(1-2):134-8. PMID: 1958827.
      View in: PubMed
    79. Resetková E, Strbák V, Hnilica P. Incidence of thyroid hormone autoantibodies in patients with thyroid diseases with respect to diagnosis, other types of autoantibodies, duration of disease and treatment. Endocrinol Exp. 1989 Jun; 23(2):105-16. PMID: 2776694.
      View in: PubMed
    80. Resetková E, Strbák V, Hnilica P, Zórad S. [Comparison of the results of radioimmunologic and hemagglutination methods in the determination of antibodies against thyroglobulin and the effect of these antibodies on thyroglobulin serum levels]. Bratisl Lek Listy. 1989 Apr; 90(4):263-7. PMID: 2765955.
      View in: PubMed
    81. Strbák V, Ouafik LH, Resetková E, Oliver C, Giraud P, Dutour A, Salers P, Randusková A. Thyrotropin releasing hormone in the pancreas of newborn rats from streptozotocin-treated mothers. Life Sci. 1989; 44(12):779-87. PMID: 2495394.
      View in: PubMed
    82. Strbák V, Huttová M, Kubasáková S, Resetková E, Randusková A, Predná E. Exchange transfusion in premature newborns: effect of maturity on thyrotropin and thyroxine responses. Endocrinol Exp. 1987 Dec; 21(4):269-73. PMID: 3501980.
      View in: PubMed
    83. Strbák V, Skultétyová M, Michalicková J, Randusková A, Macho L, Pohlová G, Resetková E. Effect of breast-feeding on infant thyroid activity: 3 year follow up--longitudinal study. Endocrinol Exp. 1986 Aug; 20(2-3):257-66. PMID: 3489599.
      View in: PubMed
    84. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology.
    85. Journal of Clinical Endocrinology and Metabolism. 78:367-374.
    86. Mammary crystalloids. International Journal of Surgical Pathology. 10:148.
    87. Thyroid lymphomas in human thyroid tissue with autoimmune thyroid disease xenografted in severe combined immunodeficient mice. Endocrine Pathology. 5:169-177.
    88. Erratum. Cancer. 115:2024.
    89. Effects of human interferon alphaofn and interferon gamma(IFNR) on xenografted human thyroid tissue in severe combined immunodeficient (SCID) and nude mice. Journal of Investigative Medicine. 44.
    90. Histopathological grading of breast ductal carcinoma In Situ. Diagnostic Pathology. 10.
    91. Even small pure tubular carcinoma of the breast (stage T1a and T1b) can be associated with lymph node metastases - The U T MD Anderson Cancer Center experience. European Journal of Surgical Oncology.
    92. Pathologic examination of breast and lymph node specimens, including sentinel lymph nodes.
    RESETKOVA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description